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Abstract Familial idiopathic basal ganglia calcification
(FIBGC) is a neurodegenerative disorder with neuropsychiatric
and motor symptoms. Deleterious mutations in SLC20A2,
encoding the type III sodium-dependent phosphate transporter
2 (PiT2), were recently linked to FIBGC in almost 50 % of the
families reported worldwide. Here, we show that knockout of
Slc20a2 in mice causes calcifications in the thalamus, basal
ganglia, and cortex, demonstrating that reduced PiT2 expres-
sion alone can cause brain calcifications.
Keywords SLC20A2 . Brain calcification . Phosphate
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Introduction
Familial idiopathic basal ganglia calcification (FIBGC), which
formerly was called “Fahr’s disease” and now also is called
primary familial brain calcification, is characterized by symmet-
rical calcifications of the basal ganglia and other brain regions
such as the thalamus and cerebellum (Sobrido et al. 2004). The
neuropsychiatric and motor symptoms are very heterogeneous,
including dementia, psychosis, parkinsonism, dystonia, and mi-
graine. Brain computed tomography has led to more frequent
detection of brain calcification, but FIBGC is a rare genetic
disease usually with an autosomal dominant inheritance, and
there are now clear genetic culprits. Wang et al. (2012) showed
that deleterious mutations in SLC20A2, encoding the type III
sodium-dependent inorganic phosphate (Pi) transporter PiT2,
were found in affected families from China, Brazil, and Spain.
Thereafter, several other kindred carrying SLC20A2 mutations
were reported in various countries (Schottlaender et al. 2012;
Hsu et al. 2013; Lemos et al. 2013; Nicolas et al. 2013; Zhang
et al. 2013). The mutation type varies, and some lead to trun-
cated mRNA that is most likely degraded, and some lead to
PiT2 proteins that are shown or predicted to be unable to
transport Pi (Bøttger and Pedersen 2002, 2011; Wang et al.
2012; Hsu et al. 2013; Zhang et al. 2013). Mutations in
SLC20A2 can, however, not account for all cases of FIBGC,
and mutations in the PDGFRB gene, which encodes a receptor
for members of the platelet-derived growth factor family, have
also been linked to the disease (Nicolas et al. 2013). It is
therefore of great importance to evaluate to which degree the
load of PiT2 alone can contribute to the development of brain
calcification. To investigate the role of PiT2 in FIBGC, we
established Slc20a2 homozygous knockout mice. We here
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report on 19-week-old Slc20a2 knockout mice with calcifica-
tions in the thalamus, basal ganglia, and brain cortex.
Materials and Methods
Animals
Transgenic C57BL/6NTac mice (C57BL/6NTac-Slc20a2tm1a-
(EUCOMM)Wtsi/Ieg (EM: 05549)) were obtained from the
European Mouse Mutant Archive, Germany. The strain is het-
erozygous for the knockout cassette, L1L2-PGK-P, inserted in
Slc20a2 after exon 2 and flanking exon 3. It introduces splice
acceptor and SV40 polyadenylation sequences in Slc20a2
between the second and third coding exons (http://www.
knockoutmouse.org/martsearch/project/24503). The mice were
housed in the Health Faculty Animal Facility at Aarhus
University, Denmark. All mice were fed the same standard diet
ad libitum and handled according to the Danish Animal Welfare
guidelines. Two 19-week-old mice homozygous for the knock-
out cassette and two 22-week-old wild-type (wt) mice from the
same heterozygous breeding pair (as controls) were sacrificed.
The male and female, which were homozygous for the knockout
cassette, showed similar patterns of calcifications in their brains,
while no calcifications were detected in the male and female
wt mice.
Genotyping
DNA was purified from tail tissue by overnight incubation at
58 °C in Laird’s buffer (Laird et al. 1991) (200 mM NaCl,
100 mM Tris–HCl pH 8.5, 5 mM EDTA pH 8.0, 0.2 % SDS)
with proteinase K (no. EO0491; Thermo Scientific). The DNA
was then precipitated in 2-propanol and redissolved in TE buffer
(10 mM Tris–HCl, 1 mM EDTA, pH 8.0). All mice were
genotyped by PCR using the Phusion Hot Start II High-
Fidelity DNA Polymerase (no. F-549S; Thermo Scientific).
Three primers were used: positioned upstream of, downstream
of, and inside the L1L2-PGK-P cassette (LAR3), respectively.




The PCR products were separated by agarose gel electro-
phoresis using the GeneRuler 100 bp Plus DNA Ladder
(Fermentas) as a size marker. The wt and knockout products
are 523 and 443 bp, respectively.
Quantitative Reverse Transcription PCR Analysis
Cultured mouse tail fibroblasts were lysed using lysis/binding
buffer containing guanidinium thiocyanate provided with the
Fig. 1 Genotyping and Slc20a2
mRNA levels. a Genotyping of
breeders heterozygous for the
knockout cassette (−/+) and of
homozygous (−/−) and wt (+/+)
offspring. Black arrow, 500-bp
size marker. White arrows, 523-
bp PCR product derived from wt
allele (upper) and 443-bp PCR
product derived from allele with
inserted knockout cassette
(lower). b Tail fibroblasts from a
Slc20a2 knockout mouse (−/−)
and three wt mice were lysed, and
Slc20a2 mRNA levels were
evaluated by qRT-PCR using
primers positioned downstream
of the knockout cassette. Slc20a2
mRNA levels relative to B2M are
shown. Error bars represent
standard deviations
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RNAqeous®-4PCR Kit (Applied Biosystems). RNA was puri-
fied from the lysates using the RNAqeous®-4PCR Kit as
described by the manufacturer and quantified by UV spec-
trometry. Immediately after purification, it was reverse tran-
scribed to cDNA using the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems). For quantitative PCR
analysis, the following TaqMan® Gene Expression Assays
(Applied Biosystems) were employed: Mm00660204
(Slc20a2) and, as endogenous control, Mm00437762 (beta-2-
microglobulin (B2M)). The individual quantitative PCR (qPCR)
reactions contained 10 μl TaqMan Fast Universal PCR Master
Mix, 1 μl TaqMan Gene Expression Assay (Slc20a2 FAM), 1 μl
TaqMan Gene Expression Assay (B2M VIC), and 8 μl cDNA
(approximately 10 ng). The PCR cycles employed were as
follows: 95 °C for 10 min and 40 cycles of 95 °C for 1 s and
60 °C for 20 s. The relative mRNA levels were calculated as
described inHellemans et al. (2007). Each qPCR reactionwas set
up as triplicates.
Histology
Brains were fixed in 4 % paraformaldehyde (formalin 10 %
buffered (VWR)) for at least 2 days and then embedded in
paraffin. Histological stainings were performed on 4-μm sections
Fig. 2 Histology of calcifications
in brain sections from
homozygous Slc20a2 knockout
mouse. a, bVonKossa staining of
thalamus regions showing
multiple calcifications as black
conglomerates in a 19-week-old
homozygous Slc20a2 knockout
mouse (a), but not in a 21-week-
old wt mouse (b) (scale bars,
300 μm). The calcifications are
composed of smaller elements
seen both in Von Kossa (c) and
HE (d) stainings. In sections
stained for macrophages/
microglia (F4/80), a tissue
reaction is demonstrated (e), but
not in the wt control (not shown)
(scale bars, 50 μm).
Calcifications were also found in
other brain regions, as seen by
Von Kossa staining of the basal
ganglia (f) and cortex (g) (scale
bars, 100 μm)
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from formalin-fixed, paraffin-embedded tissue. The sections
were deparaffinized in xylene and rehydrated.
For detection of calcium, sections were stained with the Von
Kossa staining technique. The sections were incubated
20 min in 10 % silver nitrate, rinsed in sterile water, follow-
ed by 2 min in 5 % pyrogallol. The sections were rinsed
again in sterile water and, afterwards, were placed in 5 %
sodium thiosulfate for 5 min. For counterstaining, eosin 2.1 %
was used.
For immunohistochemical staining, the sections were
emerged in H2O2 for 10 min to abolish endogenous peroxi-
dase activity. Antigen retrieval was performed by boiling in
TEG (10 mM Tris–HCl, 0.5 mM EGTA, pH 9.0) in a micro-
wave oven for 15min. F4/80 was detected using a rat antibody
to murine F4/80 (1:100; AbD Serotec, Bio-Rad). As second-
ary antibody, a rabbit antibody to rat immunoglobulins (IgG1,
IgG2a, and IgG2b) (1:200, E0468; Dako) was used. The
sections were then exposed to a goat antibody to rabbit
immunoglobulins conjugated with a peroxidase-labeled
polymer (Dako EnVision®+ System-HRP Labelled Polymer
Anti-Rabbit, K4003; Dako). The presence of peroxidase ac-
tivity was visualized by incubation with DAB+ (K3468;
Dako). Lastly, the sections were stained with Mayer’s
hematoxylin (Ampliqon), to visualize cell nuclei. In
between each step, the sections were washed in TNT buffer
(Fagron).
Hematoxylin–eosin (HE) staining was performed using a
standard protocol. Periodic acid-Shiff (PAS) staining was
performed using a standard protocol; Mayer’s hematoxylin
was used as counterstain.
Results
To establish Slc20a2 homozygous knockout mice, we used the
Slc20a2tm1a(EUCOMM)Wtsi allele on a C57BL/6NTac background
obtained from the European Mouse Mutant Archive. The
targeting vector introduced a splice acceptor and SV40
polyadenylation sequences between the second and third cod-
ing exons in Slc20a2, which leads to a premature stop of
transcription. The truncated RNA lacks eight downstream cod-
ing exons and does not code for any functional gene. Breeding
of heterozygous Slc20a2tm1a(EUCOMM)Wtsi mice resulted in via-
ble mice homozygous for the mutation (Fig. 1a) in aMendelian
ratio. To test for knockout of Slc20a2, we used primers posi-
tioned downstream of the knockout cassette and quantified the
expression level by a quantitative reverse transcription (RT)-
PCR (qRT-PCR) analysis. As seen in Fig. 1b, the mouse
homozygous for the knockout cassette shown in Fig. 2 has no
expression of Slc20a2 downstream of the cassette. In sections
from the brain, we found extensive, bilateral irregular aggre-
gates of calcified spheres in the thalamus using Von Kossa
staining (Fig. 2a). The spheres were about 10 μm in diameter,
and the size of the aggregates was about 50–100 μm
(Fig. 2c, d). A few calcifications were also found in the basal
ganglia (Fig. 2f) and in the cortex (Fig. 2g). There were no
calcifications observed in the cerebellum (not shown). No
calcifications were detected in wt controls (Fig. 2b). Tissue
reaction to the calcification was demonstrated by immuno-
histochemistry showing F4/80 positive microglia surround-
ing the individual elements of the calcified aggregates
(Fig. 2e). No other lesions were observed in the brain,
and there was no additional focal increase in microglia.
The calcifications in FIBGC are believed to initiate in or
around blood vessels (Sobrido et al. 2004). Interestingly,
PAS staining suggest that this is also the case in the
homozygous Slc20a2 knockout mouse (Fig. 3). The results
show that knockout of Slc20a2 alone is sufficient to cause
FIBGC-like calcifications in mice and support the signifi-
cance of the linkage between mutations in SLC20A2 and
FIBGC.
Fig. 3 PAS staining of brain sections from homozygous Slc20a2 knock-
out mouse. Calcifications (purple stains) in close relation to blood vessels,
delineated by the PAS-positive basal membrane, are found in the basal
ganglia (a), thalamus (b), and cortex (not shown) (scale bars, 30 μm). No
calcifications/lesions were observed in wt control (not shown)
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Discussion
PiT2 has a paralog, PiT1, encoded by the gene SLC20A1.
The two ubiquitously expressed Pi transporters (Uckert
et al. 1998) share some transport characteristics (Bøttger
et al. 2006), but differ in others (Bøttger et al. 2006;
Byskov et al. 2012). PiT1 is shown to be involved in
calcification in the medial layer of blood vessels (Li et al.
2006; Koleganova et al. 2009), and it is well-accepted that
the calcification is a cell-mediated process but debated to
which degree vascular smooth muscle cells and pericytes
contribute to the calcification. Since the calcifications in
FIBGC are believed to initiate in or around blood vessels
(Sobrido et al. 2004), and the results on the Slc20a2
knockout mouse are in agreement with this, it is tempting
to speculate that the mechanism is similar to the one
involving PiT1, where vascular smooth muscle cells trans-
differentiate to mineralizing osteoblast-like cells, possibly
caused by elevated extracellular Pi levels (Jono et al. 2000)
or by contact with precipitated calcium phosphate products
(Sage et al. 2011; Villa-Bellosta et al. 2011). Medial vas-
cular calcification is strongly linked to increased levels of
Pi in the blood (Covic et al. 2009). In FIBGC, the blood Pi
levels are within the normal range (Sobrido et al. 2004).
However, it is possible that a decrease in functional PiT2
leads to a local increase in extracellular Pi. SLC20A2 and
Slc20a2 have the highest expressions in the affected areas
(Lagrue et al. 2010; Silva et al. 2013), and it is, therefore,
likely that PiT2 is especially important for maintaining
phosphate homeostasis in the affected areas and that only
these experience an increase in extracellular Pi concentra-
tion. In these areas, the local increase in Pi concentration
alone might trigger a cell-mediated mineralization process,
or it may lead to passive precipitation of calcium phos-
phate products, which might trigger a cell-mediated miner-
alization process, thus leading to an escalation of the calcifi-
cation. However, the actual mechanism for the development
of brain calcifications in the close to 50 % of FIBGC-affected
families with an established link to mutations in
SLC20A2 yet remains to be identified. We therefore
expect that the Slc20a2 knockout mouse will develop
into an important tool for the study of development of
brain calcifications and as a preclinical model for drug
testing.
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